Virtual Medicinal Product (VMP) - Oxazepam 2mg/5ml oral suspension
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Oxazepam 2mg/5ml oral suspension | Start Date 25-09-2007 | End Date |
Unit Dose & Form Information
- DF Indicator
- Continuous
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- Schedule 4 (CD Benz)
- Route
- Oral
- Form
- Oral suspension
- Ontology Form/Route
- suspension.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- N05BA04
- BNF Codes
-
- BNF code 04010200
| Code | Start Date | End Date |
|---|---|---|
| 12142011000001101 | 25-09-2007 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Oxazepam | Based on Ingredient Substance | 400 microgram | 1 ml |
Name
Oxazepam
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
400.0
Strength and UOM (Dmr)
1.0
Parent Products
-
VTMOxazepam
-
VMP(Current) Oxazepam 2mg/5ml oral suspension
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 1 ml |